The involvement of GP73 in promoting SCAP stabilization, SCAP Golgi localization and the increased formation of SCAP-SREBP complex regardless of cholesterol content implicates its pathological roles in hepatic steatosis and HCC progression. The gene discussed is SCAP; the disease is hepatocellular carcinoma.